A randomized multi-center blinded placebo-controlled study with an open-label run-in period to evaluate the efficacy safety and pharmacokinetics of daily single subcutaneous injections of r-metHuIL-1ra [Anakinra] in polyarticular-course juvenile rheumatoid arthritis

Trial Profile

A randomized multi-center blinded placebo-controlled study with an open-label run-in period to evaluate the efficacy safety and pharmacokinetics of daily single subcutaneous injections of r-metHuIL-1ra [Anakinra] in polyarticular-course juvenile rheumatoid arthritis

Completed
Phase of Trial: Phase II/III

Latest Information Update: 10 Mar 2016

At a glance

  • Drugs Anakinra (Primary)
  • Indications Juvenile rheumatoid arthritis
  • Focus Adverse reactions
  • Sponsors Amgen
  • Most Recent Events

    • 01 Feb 2009 Results published in Clinical Rheumatology.
    • 09 Jan 2007 Status change
    • 26 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top